首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer nanotechnology

缩写:

ISSN:1868-6958

e-ISSN:1868-6966

IF/分区:4.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引101
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Connie D Cao,J Robert McCorkle,Derek B Allison et al. Connie D Cao et al.
Background: Ovarian cancer typically presents at an advanced stage, has a poor prognosis, and is a leading cause of cancer-related deaths in women. Extracellular vesicles (EVs) are cell membrane derived nanoparticles that...
Youwei Zhou,Sheng Cheng,Lei Shu et al. Youwei Zhou et al.
Objective: The targets and active components that affect the prognosis of cervical cancer remain unclear. Methods: Three microarray dat...
Rebekah Anamarie Gundersen,Tianyuan Chu,Kiana Abolfathi et al. Rebekah Anamarie Gundersen et al.
Background: Combining the power of magnetic guidance and the biological activities of stem cells transformed into biohybrid microrobots holds great promise for the treatment of several diseases including cancer. ...
Kyle Bromma,Wayne Beckham,Devika B Chithrani Kyle Bromma
Background: Much in vitro research on the applicability of gold nanoparticles (GNPs) in cancer treatment has been focused on two-dimensional (2D) monolayer models. To improve this, we explored the effect of the combinatio...
Nolan Jackson,Iona Hill,Abdulaziz Alhussan et al. Nolan Jackson et al.
Background: Radiotherapy (RT) is an essential component in the treatment regimens for many cancer patients. However, the dose escalation required to improve curative results is hindered due to the normal tissue toxicity t...
Fatemeh Zahedipour,Parvin Zamani,Mohammad Mashreghi et al. Fatemeh Zahedipour et al.
Background: The vascular endothelial growth factor receptor-2 (VEGFR-2) plays an important role in melanoma development and progression. Peptide vaccines have shown great potential in cancer immunotherapy by targeting VEG...
Weiwei Sun,Lili Dai,Yuqing Cao et al. Weiwei Sun et al.
Tumor microparticles (T-MPs) are considered as a tumor vaccine candidate. Although some studies have analyzed the mechanism of T-MPs as tumor vaccine, we still lack understanding of how T-MPs stimulate a strong anti-tumor immune response. H...
Yifan Liu,Wenxu Cheng,HongYi Xin et al. Yifan Liu et al.
Lung cancer is the leading cause of cancer mortality. As a heterogeneous disease, it has different subtypes and various treatment modalities. In addition to conventional surgery, radiotherapy and chemotherapy, targeted therapy and immunothe...
Anis Askarizadeh,Mohammad Mashreghi,Elaheh Mirhadi et al. Anis Askarizadeh et al.
Background: Colorectal cancer is one of the prominent leading causes of fatality worldwide. Despite recent advancements within the field of cancer therapy, the cure rates and long-term survivals of patients suffering from...
Muskan Goel,Yuri Mackeyev,Sunil Krishnan Muskan Goel
In the last three decades, radiopharmaceuticals have proven their effectiveness for cancer diagnosis and therapy. In parallel, the advances in nanotechnology have fueled a plethora of applications in biology and medicine. A convergence of t...